scholarly journals Microstructural changes in prodromal dementia with Lewy bodies compared to normal aging: multiparametric quantitative MRI evidences

Author(s):  
Eléna Chabran ◽  
Mary Mondino ◽  
Vincent Noblet ◽  
Laetitia Degiorgis ◽  
Paulo Loureiro de Sousa ◽  
...  
2014 ◽  
Vol 262 (1) ◽  
pp. 165-172 ◽  
Author(s):  
Li Su ◽  
Andrew M. Blamire ◽  
Rosie Watson ◽  
Jiabao He ◽  
Benjamin Aribisala ◽  
...  

2021 ◽  
pp. 089198872110235
Author(s):  
Kathryn A. Wyman-Chick ◽  
Lauren R. O’Keefe ◽  
Daniel Weintraub ◽  
Melissa J. Armstrong ◽  
Michael Rosenbloom ◽  
...  

Background: Research criteria for prodromal dementia with Lewy bodies (DLB) were published in 2020, but little is known regarding prodromal DLB in clinical settings. Methods: We identified non-demented participants without neurodegenerative disease from the National Alzheimer’s Coordinating Center Uniform Data Set who converted to DLB at a subsequent visit. Prevalence of neuropsychiatric and motor symptoms were examined up to 5 years prior to DLB diagnosis. Results: The sample included 116 participants clinically diagnosed with DLB and 348 age and sex-matched (1:3) Healthy Controls. Motor slowing was present in approximately 70% of participants 3 years prior to DLB diagnosis. In the prodromal phase, 50% of DLB participants demonstrated gait disorder, 70% had rigidity, 20% endorsed visual hallucinations, and over 50% of participants endorsed REM sleep behavior disorder. Apathy, depression, and anxiety were common prodromal neuropsychiatric symptoms. The presence of 1+ core clinical features of DLB in combination with apathy, depression, or anxiety resulted in the greatest AUC (0.815; 95% CI: 0.767, 0.865) for distinguishing HC from prodromal DLB 1 year prior to diagnosis. The presence of 2+ core clinical features was also accurate in differentiating between groups (AUC = 0.806; 95% CI: 0.756, 0.855). Conclusion: A wide range of motor, neuropsychiatric and other core clinical symptoms are common in prodromal DLB. A combination of core clinical features, neuropsychiatric symptoms and cognitive impairment can accurately differentiate DLB from normal aging prior to dementia onset.


2016 ◽  
Vol 12 ◽  
pp. P473-P473
Author(s):  
Frederic Blanc ◽  
Daniel Roquet ◽  
Vincent Noblet ◽  
Benjamin Cretin ◽  
Julien Lamy ◽  
...  

2006 ◽  
Vol 14 (7S_Part_31) ◽  
pp. P1645-P1646
Author(s):  
Kathryn A. Wyman-Chick ◽  
Lauren O. Erickson ◽  
Michael H. Rosenbloom ◽  
Terry R. Barclay ◽  
Julia C. Johnson ◽  
...  

2019 ◽  
Vol 34 (5) ◽  
pp. 635-646 ◽  
Author(s):  
Rory Durcan ◽  
Paul Donaghy ◽  
Curtis Osborne ◽  
John‐Paul Taylor ◽  
Alan J. Thomas

2018 ◽  
Vol 49 (3) ◽  
pp. 396-402 ◽  
Author(s):  
Alan J. Thomas ◽  
Paul Donaghy ◽  
Gemma Roberts ◽  
Sean J. Colloby ◽  
Nicky A. Barnett ◽  
...  

AbstractBackgroundDopaminergic imaging has high diagnostic accuracy for dementia with Lewy bodies (DLB) at the dementia stage. We report the first investigation of dopaminergic imaging at the prodromal stage.MethodsWe recruited 75 patients over 60 with mild cognitive impairment (MCI), 33 with probable MCI with Lewy body disease (MCI-LB), 15 with possible MCI-LB and 27 with MCI with Alzheimer's disease. All underwent detailed clinical, neurological and neuropsychological assessments and FP-CIT [123I-N-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)] dopaminergic imaging. FP-CIT scans were blindly rated by a consensus panel and classified as normal or abnormal.ResultsThe sensitivity of visually rated FP-CIT imaging to detect combined possible or probable MCI-LB was 54.2% [95% confidence interval (CI) 39.2–68.6], with a specificity of 89.0% (95% CI 70.8–97.6) and a likelihood ratio for MCI-LB of 4.9, indicating that FP-CIT may be a clinically important test in MCI where any characteristic symptoms of Lewy body (LB) disease are present. The sensitivity in probable MCI-LB was 61.0% (95% CI 42.5–77.4) and in possible MCI-LB was 40.0% (95% CI 16.4–67.7).ConclusionsDopaminergic imaging had high specificity at the pre-dementia stage and gave a clinically important increase in diagnostic confidence and so should be considered in all patients with MCI who have any of the diagnostic symptoms of DLB. As expected, the sensitivity was lower in MCI-LB than in established DLB, although over 50% still had an abnormal scan. Accurate diagnosis of LB disease is important to enable early optimal treatment for LB symptoms.


2020 ◽  
Vol 35 (5) ◽  
pp. 859-867 ◽  
Author(s):  
Marleen Beek ◽  
Inger Steenoven ◽  
Jessica J. Zande ◽  
Frederik Barkhof ◽  
Charlotte E. Teunissen ◽  
...  

2021 ◽  
pp. 102908
Author(s):  
Ryota Kobayashi ◽  
Daichi Morioka ◽  
Akihito Suzuki ◽  
Shinobu Kawakatsu ◽  
Koichi Otani

Sign in / Sign up

Export Citation Format

Share Document